Philadelphia, PA, United States of America

Ming Zhang

This inventor holds 1 USPTO granted patent. Top assignees: Organix, Inc., Temple University, Virginia Commonwealth University. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ming Zhang. Retrieved from https://idiyas.com/inventor/ming-zhang-gdtp88lt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ming Zhang

Introduction

Ming Zhang is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of inflammation therapy, particularly concerning central nervous system conditions. His innovative approach utilizes cannabinoid agonists to provide therapeutic benefits.

Latest Patents

Ming Zhang holds a patent for a method of treating patients suffering from central nervous system inflammation. This method involves administering a therapeutically effective amount of a cannabinoid agonist that has efficacy at the CB receptor while having substantially no efficacy at the CB receptor at that amount. This innovative therapy offers a promising avenue for treating inflammation-related disorders.

Career Highlights

Throughout his career, Ming Zhang has worked with notable institutions, including Virginia Commonwealth University and Organix, Inc. His work in these organizations has allowed him to develop and refine his innovative approaches to therapy.

Collaborations

Ming Zhang has collaborated with several professionals in his field, including Billy R. Martin and Mohamad I. Damaj. These collaborations have contributed to the advancement of his research and the development of his patented methods.

Conclusion

Ming Zhang's contributions to inflammation therapy highlight his innovative spirit and dedication to improving patient care. His work continues to influence the field and offers hope for those affected by central nervous system inflammation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…